A LABSTOP day to refuel and meet HoloMonitor

November 2, 2020 | Blog | Lund

We had a great day at SmiLe Incubator #LABSTOP where the SmiLe community used the opportunity to try hands-on our HoloMonitor Live Cell Imaging & Analysis system!

It makes us proud to be gold lab sponsor of SmiLe Incubator. SmiLe is a local business incubator in Lund, specialized in life science. Through our collaboration, HoloMonitor M4 is accessible for use through the Open Lab Skåne project.

Thank you to everyone who talked to us at our stand at SmiLe LABSTOP, joined our HoloMonitor seminars and put their lab gloves on for seeing their living, happy cells during our hands-on lab demos 🙂

Enjoy swooshing through the day in 60 seconds!

Curious about using HoloMonitor at SmiLe? Please get in touch with PHI specialist Lisa.

You missed our Application Specialist seminars on HoloMonitor and its application in cell-based research? Check out our free Webinars on Live Cell Imaging & Analysis to learn more!

Latest Blogs

Publication-highlight

2023 publication highlights

In 2023, cell researchers all over Europe, the USA, and Asia continued to show the versatility of HoloMonitor in their innovative research. In this blog, we present the researchers behind these studies and delve into the HoloMonitor publication highlights 2023 that unlock our cells’ secrets…
Learn more …
App Suite 4.0 App Overview In Software

The App Suite 4.0 with fluorescence software update

With the HoloMonitor App Suite 4.0 software update, we provide you with numerous enhancements to make your research smoother and more insightful. However, the highlight is the integration of fluorescence capture and analysis using the HoloMonitor M4 add-on fluorescence unit.
Learn more …
BioPhotonics-article-QPI-regenerative-medicine-cover

BioPhotonics article on how QPI advances Regenerative Medicine (Issue 07/08 2023)

The BioPhotonics July/August 2023 issue holds a feature article by PHI highlighting how HoloMonitor’s quantitative phase imaging (QPI) technology has the potential to propel regenerative medicine forward.
Learn more …
See All Blogs